Who owns BioXcel Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings.
Institutional ownership of BTAI from SEC Form 13F filings across 38 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 38 institutions disclosed 4.6M shares of BioXcel Therapeutics, Inc. worth $6.4M — about 15.1% of shares outstanding; the largest disclosed holder is MILLENNIUM MANAGEMENT LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
38
13F holders
$6.4M
value, 2026 filers
15.1%
of shares outstanding (4.6M sh)
9
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of BTAI's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | MILLENNIUM MANAGEMENT LLC | 2.1M | $3.0M | 0.0% | 7% | +9.2% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 919,545 | $1.3M | 0.0% | 3% | +121.7% |
| 3 | Oaktree Fund Advisors, LLC | 245,585 | $346,274 | 0.6% | 0.8% | +186.1% |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 242,251 | $341,911 | 0.0% | 0.8% | +5.2% |
| 5 | BlackRock, Inc. | 179,433 | $253,001 | 0.0% | 0.6% | +112.9% |
| 6 | UBS Group AG | 158,065 | $222,871 | 0.0% | 0.5% | +199.4% |
| 7 | CITADEL ADVISORS LLCNEW | 149,220 | $210,400 | 0.0% | 0.5% | new |
| 8 | VANGUARD FIDUCIARY TRUST CO | 136,937 | $193,081 | 0.0% | 0.5% | +61.3% |
| 9 | FMR LLC | 90,300 | $127,323 | 0.0% | 0.3% | 0.0% |
| 10 | &PARTNERS | 83,588 | $117,859 | 0.0% | 0.3% | +3.4% |
| 11 | JONES FINANCIAL COMPANIES LLLP | 63,139 | $82,712 | 0.0% | 0.2% | -52.1% |
| 12 | NORTHERN TRUST CORP | 56,318 | $79,408 | 0.0% | 0.2% | +55.1% |
| 13 | HighTower Advisors, LLC | 41,000 | $57,810 | 0.0% | 0.1% | 0.0% |
| 14 | StoneX Group Inc.NEW | 20,684 | $29,164 | 0.0% | 0.1% | new |
| 15 | SUSQUEHANNA INTERNATIONAL GROUP, LLPNEW | 17,200 | $24,252 | 0.0% | 0.1% | new |
| 16 | OSAIC HOLDINGS, INC. | 16,214 | $22,860 | 0.0% | 0.1% | 0.0% |
| 17 | Diversify Advisory Services, LLCNEW | 15,000 | $13,005 | 0.0% | 0% | new |
| 18 | DIVERSIFY WEALTH MANAGEMENT, LLC | 15,000 | $13,005 | 0.0% | 0% | 0.0% |
| 19 | TWO SIGMA SECURITIES, LLCNEW | 10,796 | $15,222 | 0.0% | 0% | new |
| 20 | WELLS FARGO & COMPANY/MN | 4,337 | $6,115 | 0.0% | 0% | +0.4% |
| 21 | CITIGROUP INCNEW | 2,998 | $4,227 | 0.0% | 0% | new |
| 22 | MORGAN STANLEY | 1,671 | $2,356 | 0.0% | 0% | -84.2% |
| 23 | BARCLAYS PLCNEW | 1,428 | $2,013 | 0.0% | 0% | new |
| 24 | NewEdge Advisors, LLCNEW | 1,331 | $1,877 | 0.0% | 0% | new |
| 25 | Vanguard Global Advisers, LLC | 493 | $695 | 0.0% | 0% | 0.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.